COMMUNIQUÉS West-GlobeNewswire

Earth Science Tech, Inc. (ETST) Engages Hayden IR, Expanding Investor Relations Efforts to Support its Investor Outreach and Communications
05/01/2026
MIAMI, FL, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company, today announced that it has engaged Hayden IR, a nationally recognized investor [...]
Nxera Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
05/01/2026
Tokyo, Japan and Cambridge, UK, 5 January 2026 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) announces that Chris Cargill, President and CEO, will present at the 43rd Annual J.P. Morgan Healthcare [...]
Easy Environmental Solutions Announces New Distribution Partnership to Expand Access to Terreplenish®
05/01/2026
MANKATO, Minn., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Easy Environmental Solutions, Inc. (OTC: EZES), the manufacturer of Terreplenish®, a leading organic microbial soil-replenishing technology, today announced a new [...]
PolarityBio Announces AMA Publication of New Category III CPT Codes for SkinTE® Procedures
05/01/2026
New procedural codes establish standardized pathway for clinical use of autologous heterogeneous skin construct across care settings SALT LAKE CITY, Jan. 05, 2026 (GLOBE NEWSWIRE) -- PolarityBio© , a clinical-stage [...]
Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary
05/01/2026
January 05, 2026 Biodexa Pharmaceuticals PLC Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical [...]
Wave Life Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference
05/01/2026
CAMBRIDGE, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, [...]
Xenon to Present at the 44th Annual J.P. Morgan Healthcare Conference
05/01/2026
VANCOUVER, British Columbia and BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and [...]
Ascendis Pharma to Participate in the 44th Annual J.P. Morgan Healthcare Conference
05/01/2026
COPENHAGEN, Denmark, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in the 44 th Annual J.P. Morgan Healthcare Conference and provide a [...]
rYojbaba Issues Letter to Shareholders Detailing 2025 Operational Highlights and 2026 Strategic Priorities
05/01/2026
FUKUOKA, Japan, Jan. 05, 2026 (GLOBE NEWSWIRE) -- rYojbaba Co., Ltd. (Nasdaq: RYOJ) (“rYojbaba” or the “Company”) , a Japanese labor consulting and health services company, today issued a letter to its shareholders [...]
Medera Announces Completion of Patient Enrollment in Cohort B of MUSIC-HFpEF Phase 1/2a Clinical Trial
05/01/2026
BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing next-generation therapeutics, today announced that [...]
Caring Brands Announces Exclusive Global License to Manufacture and Market Emesyl
05/01/2026
Jupiter, Fla., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Caring Brands Inc. (Nasdaq: CABR) today announced that it has entered into an exclusive worldwide license agreement with Itonis Inc. to manufacture, market, and [...]
CRISPR Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
05/01/2026
ZUG, Switzerland and BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today [...]
ProPhase Labs Provides Update on Convertible Debt Conversions, Capital Structure, and Underlying Asset Value
05/01/2026
UNIONDALE, NY, Jan. 05, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. ( OTC: PRPH ) today provided an update to shareholders regarding recent trading activity, its capital structure, and the Company’s underlying asset [...]
TME Pharma provides update on its activities
05/01/2026
TME Pharma provides update on its activities Berlin, Germany , January 5, 2025, 08.00 CET – TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company specializing in the development of novel [...]
TME PHARMA FAIT LE POINT SUR SES ACTIVITÉS
05/01/2026
TME PHARMA FAIT LE POINT SUR SES ACTIVITÉS Berlin, Allemagne, 5 janvier 2025, 8 h 00 CET – TME Pharma N.V. (Euronext Growth Paris : ALTME), une société de biotechnologie au stade clinique spécialisée dans le [...]
Nicox Announces Complete Repayment of Kreos Capital Debt and Extends Cash Runway Beyond 2027 with New Additional Financing
05/01/2026
Press Release Nicox Announces Complete Repayment of Kreos Capital Debt and Extends Cash Runway Beyond 2027 with New Additional Financing Company’s position strengthened, enabling flexibility in strategic discussions All [...]
Nicox annonce le remboursement intégral de sa dette avec Kreos Capital et étend son horizon de trésorerie au-delà de 2027 grâce à un nouveau financement complémentaire
05/01/2026
Communiqué de presse Nicox annonce le remboursement intégral de sa dette avec Kreos Capital et étend son horizon de trésorerie au-delà de 2027 grâce à un nouveau financement complémentaire La position de la Société sort [...]
Burning Rock Announces Founder’s Purchase of Its ADSs
05/01/2026
GUANGZHOU, China, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focusing on the application of next generation sequencing (NGS) technology in [...]
Idorsia’s JERAYGO (aprocitentan) approved in Canada for the treatment of resistant hypertension
05/01/2026
Idorsia receives approval from Health Canada for JERAYGO ™ (aprocitentan) as the first and only endothelin receptor antagonist (ERA) for the treatment of resistant hypertension. JERAYGO is a new oral antihypertensive [...]

Pages